27 August 2024 | 15:00-16:30

Format: Presentation
Stream: Populations

Part 1: Smart, safe, active ageing in Hong Kong – the way forward

Donald Li Elderly Commission, Hong Kong SAR, Hong Kong

 

Part 2: Care of elderly & medical-social collaboration

Tak-Yeung Chan Hospital Authority, Hong Kong

 

Part 3: Appropriate legal matters for end-of-life care

Raymond Lo British Medical Association, Hong Kong

 

Part 4: Polypharmacy and potentially-inappropriate medications in the elderly cancer patients receiving cancer treatment

Most of the elderly cancer patients have pre-existing illnesses. Excessive medications would lead not only futility, but also result in adverse outcomes. This study was a prospective cohort study conducted among the elderly non-hematologic cancer patients (= 65 years old) whom a medical oncologist had decided suitable for systemic therapy. We found that among elderly cancer patients suitable for systemic cancer therapy, around two-thirds of patients had polypharmacy (PP) and potentially inappropriate medications (PIMs). Higher co-morbidity index was the sole significant predictor of PP; while only primary lung cancer was associated with PIMs. PP was associated with unplanned hospitalization.

Chanyoot Bandidwattanawong Navamindradhiraj University, Thailand